Details of the Probe-central Interaction Altas
General Information of Experiment
Probe Name | C058 | Probe Info | ||||
---|---|---|---|---|---|---|
Probe concentration | Probe:50uM; negative probe:50uM | |||||
Criteria | Quantification: AfBPP Probe vs Negative Probe | |||||
Quantitative Method |
TMT
|
|||||
In Vivo Experiment Model | Model Type |
|
Living cell | |||
Derived Tissue |
|
Peripheral blood | ||||
Disease Model | Normal | |||||
Model Name | Human normal cells (HEK-293T) | |||||
Note | Negative probe:C#CCCC1(CCC(NC)=O)N=N1 |
Interaction Altas of This Experiment [1]
Enzyme
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP01769 | Dihydrofolate reductase (DHFR) | 9.6 | ||||
LDTP10182 | TLC domain-containing protein 1 (TLCD1) | 8.8 | ||||
LDTP09088 | Phospholipase A2 group XV (PLA2G15) | 7.7 | ||||
LDTP06375 | Delta(24)-sterol reductase (DHCR24) | 6.2 | ||||
LDTP12020 | Histone-lysine N-methyltransferase SMYD3 (SMYD3) | 6.1 | ||||
LDTP04285 | Proteasome subunit beta type-2 (PSMB2) | 5.9 | ||||
LDTP06333 | Serum paraoxonase/arylesterase 2 (PON2) | 5.0 |
Transporter and channel
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP03952 | Reduced folate transporter (SLC19A1) | 5.4 | ||||
LDTP10958 | Sigma non-opioid intracellular receptor 1 (SIGMAR1) | 4.9 |
Other
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP15623 | Neuferricin (CYB5D2) | 5.1 |